Published in Contemp Top Immunobiol on January 01, 1978
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J Exp Med (1980) 1.91
Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci U S A (1979) 1.59
Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer (1979) 1.22
Quantitative studies of natural immunity to solid tumours in rats. Persistence of natural immunity throughout reproductive life, and absence of suppressor cells in infant rats. Immunology (1980) 1.15
Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 0.99
Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release. Clin Exp Immunol (1982) 0.93
Review: Immunogenetics of human placentation. Placenta (2011) 0.92
Electron microscopic study of natural killer cell-tumor cell conjugates. Proc Natl Acad Sci U S A (1982) 0.88
Reduced killer cell activity of lymphocytes from patients with asbestosis. Br J Ind Med (1985) 0.88
Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease. Clin Exp Immunol (1981) 0.86
Activation of p44/42 MAPK plays a role in the TBT-induced loss of human natural killer (NK) cell function. Cell Biol Toxicol (2010) 0.86
NK cell activity and skin test antigen stimulation of NK like CMC in vitro are decreased to different degrees in pregnancy and sarcoidosis. Clin Exp Immunol (1984) 0.85
Tetrabromobisphenol A decreases cell-surface proteins involved in human natural killer (NK) cell-dependent target cell lysis. J Immunotoxicol (2011) 0.84
Relationship of natural killer-cell activity to rhesus antigens in man. Br J Cancer (1979) 0.83
Effects of a series of triorganotins on ATP levels in human natural killer cells. Environ Toxicol Pharmacol (2008) 0.83
Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cells. J Appl Toxicol (2012) 0.83
Immunosuppressive effects of triclosan, nonylphenol, and DDT on human natural killer cells in vitro. J Immunotoxicol (2010) 0.82
In vitro augmentation of human natural cytotoxic activity. Clin Exp Immunol (1981) 0.82
Suppression by radioactive strontium of the spontaneous cytotoxicity expressed by adherent, predominantly phagocytic cells from various mouse tissues. Immunology (1979) 0.82
Pentachlorophenol decreases ATP levels in human natural killer cells. J Appl Toxicol (2008) 0.82
Serum interferon levels and natural killer cell activity in patients with asbestosis. Thorax (1984) 0.82
Antiviral cell-mediated immune responses and effect of chromosome polymorphism in Herpesvirus saimiri-infected monkeys. Infect Immun (1980) 0.80
Inhibition of cell proliferation rather than of cell lysis as a measure of immune reactivity in embryo-antigen-challenged mice. Br J Cancer (1981) 0.79
Monoclonal antibody anti-NC-2 identifies a second receptor on cells mediating natural cytotoxicity in mice. Immunology (1998) 0.79
The effect of BCG stimulation on natural cytotoxicity in the rat. Immunology (1980) 0.78
Serum supplementation modulates the effects of dibutyltin on human natural killer cell function. Toxicol Sci (2008) 0.78
Activation of p44/42 in human natural killer cells decreases cell-surface protein expression: Relationship to tributyltin-induced alterations of protein expression. Toxicol Mech Methods (2010) 0.78
Effects of butyltin exposures on MAP kinase-dependent transcription regulators in human natural killer cells. Toxicol Mech Methods (2010) 0.76
Antibody-dependent cellular cytotoxicity in cancer patients: lack of prognostic value. Br J Cancer (1980) 0.75
Natural killer cell activity in untreated systemic lupus erythematosus. Ann Rheum Dis (1982) 0.75
Mice treated with strontium 90: an animal model deficient in NK cells. Br J Cancer (1981) 0.75
Glutathione diminishes tributyltin- and dibutyltin-induced loss of lytic function in human natural killer cells. Drug Chem Toxicol (2009) 0.75
Lysis-sensitive targets stimulate an elevation of cAMP in human natural killer cells. Immunology (1998) 0.75
Activation of protein kinase C and protein kinase D in human natural killer cells: effects of tributyltin, dibutyltin, and tetrabromobisphenol A. Toxicol Mech Methods (2015) 0.75
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 9.73
"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61
Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell (1986) 4.92
"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol (1975) 4.86
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol (2001) 3.65
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol (1990) 3.44
Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol (1988) 3.32
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci U S A (1983) 3.17
An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev (1979) 3.15
The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000) 3.09
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol (1977) 3.05
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Host gene influences sensitivity to interferon action selectively for influenza virus. Nature (1980) 2.88
Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol (1992) 2.88
Inborn resistance of ice to orthomyxoviruses. Curr Top Microbiol Immunol (1981) 2.41
Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol (2001) 2.40
Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature (1977) 2.39
Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol (1985) 2.38
Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. J Immunol (1982) 2.32
Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol (1978) 2.29
Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses. Virology (1985) 2.26
Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med (1979) 2.14
Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med (1976) 2.11
Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice. J Biol Chem (1985) 2.10
The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes. J Exp Med (1988) 2.04
Transcriptional activation of the mouse Mx gene by type I interferon. Mol Cell Biol (1986) 2.04
Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. Interferon (1987) 1.99
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95
A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J Virol (1988) 1.90
The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett (1999) 1.81
Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc Natl Acad Sci U S A (1999) 1.78
Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol (1996) 1.76
Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J Virol (1995) 1.73
Mx-dependent resistance to influenza viruses is induced by mouse interferons alpha and beta but not gamma. Virology (1984) 1.71
Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol Cell Biol (1985) 1.70
Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J Infect Dis (1995) 1.70
Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. Scand J Immunol (1978) 1.70
Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med (1994) 1.66
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology (1998) 1.60
Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS (1997) 1.58
Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol (1995) 1.56
Activity of rat Mx proteins against a rhabdovirus. J Virol (1990) 1.52
Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis. Clin Exp Immunol (1990) 1.51
Human fetal thymus and bone marrow contain target cells for natural killer cells. Eur J Immunol (1981) 1.51
Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol (1996) 1.51
YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol (1985) 1.51
Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med (1998) 1.50
Inborn resistance of mice to myxoviruses: macrophages express phenotype in vitro. J Exp Med (1978) 1.46
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br J Cancer (2004) 1.45
Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol (1997) 1.44
Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature (1980) 1.42
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. J Exp Med (1989) 1.39
Natural killer cells. Prog Allergy (1981) 1.38
Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect Immun (1976) 1.35
GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J Biol Chem (1999) 1.34
Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J (1988) 1.32
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci U S A (1992) 1.31
Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. J Immunol (1982) 1.30
Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population. J Immunol (1979) 1.30
Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer (1995) 1.29
MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis (1994) 1.29
Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension (2000) 1.29
T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Eur J Immunol (1989) 1.28
Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand J Immunol (1990) 1.27
Rapid detection of influenza virus H1 by the polymerase chain reaction. Biochem Biophys Res Commun (1990) 1.26
Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J Exp Med (1981) 1.24
Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus. Virology (1980) 1.23
Corynebacterium parvum-induced peritoneal exudate cells with rapid cytolytic activity against tumour cells are non-phagocytic cells with characteristics of natural killer cells. Scand J Immunol (1978) 1.23
Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis (1990) 1.23
Athymic (nude) mice express gene for myxovirus resistance. Nature (1974) 1.23
NK cell-sensitive T-cell subpopulation in thymus: inverse correlation to host NK activity. Nature (1979) 1.20
The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int J Cancer (1994) 1.20
Nucleoprotein viral RNA and mRNA of Thogoto virus: a novel "cap-stealing" mechanism in tick-borne orthomyxoviruses? J Virol (1996) 1.20
Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16. J Virol (1986) 1.20
Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol (1977) 1.19
Generation of natural killer cells: an autonomous function of the bone marrow. J Exp Med (1977) 1.19
Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer (1975) 1.18
Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur J Immunol (1990) 1.18
Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer (1995) 1.17
Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J Virol (1991) 1.17
Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology (1980) 1.15
MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J Virol (2000) 1.14
An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice. Int J Cancer (1978) 1.13
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res (2001) 1.12
A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Eur J Immunol (1979) 1.12
Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes. J Exp Med (1979) 1.11
Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. J Immunol (1999) 1.10
Characterization and expression of the Mx1 gene in wild mouse species. Biochem Genet (1998) 1.10
A double-stranded RNA-inducible fish gene homologous to the murine influenza virus resistance gene Mx. Mol Cell Biol (1989) 1.09
Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy. Scand J Immunol (1988) 1.08
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res (1996) 1.08
Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol (1990) 1.07
Interferon-dependent genetic resistance to influenza virus in mice: virus replication in macrophages is inhibited at an early step. J Gen Virol (1980) 1.07
Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis (1998) 1.07